Related by context. All words. (Click for frequent words.) 70 Symadex 69 preclinically 69 ANAVEX #-# [001] 68 Preclinical studies 68 rBChE 68 Onconase 68 preclinical efficacy 68 iroxanadine 68 ENMD # 68 XmAb# 68 PLX cells 67 vivo validation 67 #ME# 67 OXi# 67 CCX# 67 VA# [002] 67 masitinib 67 proteasome inhibitor 67 ProSavin 67 Xanafide 66 immune modulating 66 mTOR inhibitors 66 BNC# 66 APOPTONE 66 GRN# 66 immune modulatory 66 MAGE A3 ASCI 66 ATL# [001] 66 PEG SN# 66 EndoTAG TM -1 66 vivo efficacy 66 Guanilib 66 PD LID 66 Carfilzomib 66 GRNCM1 66 Panzem 66 Homspera 66 Traficet EN 66 neuroprotective properties 66 selective inhibition 65 vidofludimus 65 PSMA ADC 65 favorable pharmacokinetic profile 65 thalidomide Thalomid 65 INCB# [001] 65 Lodamin 65 Lpathomab 65 Azedra 65 anticancer activity 65 TG# [003] 65 oral bioavailability 65 flavopiridol 65 anti fibrotic 65 immunomodulatory 65 potent anti angiogenic 65 mGluR2 NAM 65 ganetespib 65 DXL# 65 SNT MC# 65 vascular disrupting 65 PDE# inhibitors 65 CYT# potent vascular disrupting 65 JAK inhibitors 65 vascular disrupting agents 65 experimental autoimmune encephalomyelitis 65 huC# DM4 65 TRIOLEX 65 vitro experiments 65 HQK 65 OHR/AVR# 65 anti amnesic 64 plasma kallikrein inhibitor 64 PROCHYMAL 64 Tyrima 64 Sym# 64 Aplidin 64 immuno modulatory 64 Ceflatonin 64 CCR2 64 riociguat 64 PDE7 inhibitors 64 menadione 64 DFMO 64 MGd 64 ziconotide 64 CBLC# 64 antitumor effects 64 Angiolix 64 RhuDex ® 64 LY# [003] 64 glucagon receptor 64 Interferon alpha 64 Curaxin 64 HuLuc# 64 systemically administered 64 neuroregenerative 64 IMA# 64 Sphingomab 64 YONDELIS 64 vitro studies 64 HCV protease inhibitors 64 Amplimexon 64 antitumor efficacy 64 NEUGENE 64 novel peptide 64 CA4P 64 PRT# 64 tumorigenicity 64 NS#/#A protease 64 anti angiogenic agent 64 solithromycin 64 exon skipping 64 ATL/TV# 64 antagomirs 63 engineered RAP peptides 63 HuMax CD# 63 cMET 63 targeting CD# 63 Lenocta 63 Ebola SNALP 63 lomitapide 63 p# activation 63 antitumor 63 Spiegelmer ® 63 Zolinza 63 Tamibarotene 63 protein kinase inhibitor 63 Rasagiline 63 SGS# 63 vascular disrupting agent 63 cytoprotective 63 protein tyrosine phosphatase 1B 63 PEGylated 63 radiation sensitizer 63 tafamidis 63 HDAC inhibition 63 Revimmune 63 Cytolin ® 63 thrombopoietin 63 CCR9 63 selective modulator 63 ANG# 63 immunomodulator 63 thetreatment 63 Factor VIIa 63 OncoVEX 63 Protectan CBLB# 63 AEG# 63 CCR9 antagonist 63 targeted radiotherapeutic 63 PARP inhibition 63 receptor inhibitor 63 GLYX 63 Arimoclomol 63 elacytarabine 63 erythropoietic 63 histone deacetylase inhibitors 63 TriRima 63 EndoTAG TM 63 Zalypsis 63 immunomodulatory properties 63 CIMZIA ™ 63 Safinamide 63 HAAH 63 anticancer agent 63 Aliskiren 63 immunomodulatory effects 63 LT NS# 63 A3 adenosine receptor 63 oral prodrug 63 brivaracetam 63 orally administered inhibitor 63 MEK inhibitor 63 HuMax EGFr 63 Lixivaptan 63 fosbretabulin 63 neuro protective 63 iSONEP 63 endotoxemia 63 murine model 63 Anavex #-# 63 lenalidomide Revlimid R 63 bortezomib Velcade 63 NMDA receptor antagonists 63 Golimumab 63 cannabinor 63 Bezielle 63 humanized monoclonal antibodies 63 delafloxacin 63 Arikace 63 antiangiogenic 63 etanercept Enbrel 63 antidepressant efficacy 63 DP b# 62 Mipomersen 62 IRX 2 62 mouse xenograft models 62 GFT# 62 antiangiogenesis 62 IAP inhibitor 62 VEGF receptor 62 oral antiviral 62 #beta HSD1 62 triphendiol 62 CCR1 62 NP2 Enkephalin 62 Tarvacin 62 TRO# 62 samalizumab 62 ACZ# 62 plasma kallikrein 62 interferon beta therapy 62 #D#C# 62 rilonacept 62 JAK3 62 neurotrophic 62 CD# monoclonal antibody 62 histone deacetylase inhibitor 62 HIF PHI 62 Serdaxin 62 therapeutic monoclonal antibody 62 MAPK pathway 62 pan HDAC inhibitor 62 proteasome inhibitors 62 chemopreventive agent 62 xenograft models 62 chemotherapeutic drug 62 CBLB# 62 VAPRISOL 62 depsipeptide 62 mdx mouse 62 CDDO Im 62 indibulin 62 Nanobody ® 62 fibrotic disease 62 CXCR7 62 MultiStem 62 Zybrestat 62 pharmacokinetic interactions 62 KNS # 62 PDE4 inhibitor 62 ALN TTR# 62 canakinumab 62 PhG alpha 1 62 deacetylase inhibitors 62 CTAP# Capsules 62 Valortim 62 BAL# [001] 62 mertansine 62 HCV protease inhibitor 62 RNAi mediated 62 immune modulator 62 RhuDex R 62 bardoxolone methyl 62 interferon IFN 62 #F FDG PET 62 ZFP TF 62 Abbokinase 62 Cethrin 62 Aurora kinase 62 cardiac toxicity 62 alagebrium 62 DDP# 62 receptor tyrosine kinase inhibitor 62 TLR8 62 Panzem R 62 anti CD3 62 PCK# 62 antiangiogenic activity 62 Anticalin ® 62 Thiarabine 62 CG# [003] 62 Dacogen decitabine 62 tezampanel 62 BioNumerik 62 remyelination 62 Anti VEGF 62 orally bioavailable 62 OMP #M# 62 T#I [002] 62 tipifarnib 62 anti CD3 antibody 62 Epratuzumab 62 HGS# 62 R#/MEM # 62 Arcalyst 62 trabectedin 62 LSI #P 62 resolvin 62 bortezomib Velcade ® 62 antitumor effect 62 NOD mouse 62 Virulizin ® 62 CRLX# 62 demonstrated antitumor activity 62 Pentraxin 2 62 Voreloxin 62 microtubule targeting 62 preclinical models 62 retapamulin 62 Synavive 62 insulin sensitizing 62 PXD# 62 CORT # 62 NMDA antagonist 62 Revlimid lenalidomide 62 rhIL 7 62 dexpramipexole 62 ON #.Na 62 ADAGIO study 62 ISIS # 62 antisense inhibition 62 5 HT6 receptor 62 Aviptadil 62 RhuDex 62 Cyclin E 62 esophageal candidiasis 62 antisense inhibitors 62 telomerase activator 61 DermaVir 61 multitargeted 61 nucleoside analogs 61 neuronal dysfunction 61 immunomodulating 61 splice variants 61 lenalidomide dexamethasone 61 JAK inhibitor 61 ImmunoVEX HSV2 61 secretin 61 microglial activation 61 corticosteroid dexamethasone 61 oral FTY# 61 Omacetaxine 61 partial agonist 61 metaglidasen 61 pertuzumab 61 immunomodulation 61 preclinical studies 61 VEGF inhibitors 61 Alvesco R 61 HSP# inhibitor 61 ESBA# 61 atacicept 61 YONDELIS R 61 SERMs 61 nonclinical studies 61 Elesclomol 61 MEK inhibitors 61 S/GSK# 61 postoperative ileus 61 glucokinase activator 61 antitumour 61 Sudhir Agrawal D.Phil 61 immunotoxins 61 LPA1 receptor 61 small molecule defensin 61 K ras mutations 61 Tarvacin TM 61 IL #E 61 mGluR5 antagonist 61 PSN# [002] 61 Prodarsan ® 61 uricase 61 EP #R 61 Gleevec resistant 61 Dr. Pasinetti 61 ADAMTS# 61 beta interferons 61 acetonide FA 61 trodusquemine 61 small molecule activators 61 ALN TTR 61 kallikrein 61 DACH platinum 61 multi kinase inhibitor 61 Valdoxan 61 endogenous ligands 61 radezolid 61 CEQ# 61 NEUMUNE 61 diabetic neuropathic pain 61 TRAIL induced apoptosis 61 Anthim 61 deferiprone 61 EDEMA3 trial 61 vivo potency 61 nanoviricides 61 omega interferon 61 pathophysiological effects 61 pexiganan 61 PDE4 inhibitors 61 potent antitumor activity 61 INCB# [003] 61 Dr. Fehlings 61 chimeric monoclonal antibody 61 somatostatin 61 OncoVex 61 UsiRNAs 61 GSK# [001] 61 therapeutic modality 61 OXIGON TM 61 Bafetinib 61 Nanobodies 61 anti proliferative 61 ELACYT 61 Catena ® 61 ospemifene 61 nucleotide analogs 61 splice variant 61 NITD# 61 Bicifadine 61 ALGRX 61 proteasome inhibitor bortezomib 61 phase IIb clinical 61 Iloperidone 61 Teplizumab 61 NTx TM -# 61 TheraCIM 61 anti angiogenic therapy 61 Zysolin TM 61 INGN 61 nicotinic alpha 7 61 PTHrP 61 reslizumab 61 teriflunomide 61 IL 1ß 61 antitumoral 61 antifibrotic 61 rufinamide 61 oxysterols 61 BRAF inhibitor 61 PPARγ 61 Granulocyte Colony Stimulating Factor 61 Six3 61 favorable pharmacokinetic 61 telomerase inhibitor 61 potent cytotoxic 61 GPx 61 lung fibrosis 61 obatoclax 61 Certolizumab pegol 61 Squalamine 61 Ampligen ® 61 BAL# [002] 61 Src inhibitors 61 Bendavia 61 kidney urologic 61 Dr. Sosne 61 investigational humanized monoclonal antibody 61 Archexin 61 non nucleoside HCV 61 inhibit metastasis 61 daptomycin 61 inhibitor RG# 61 Triolex 61 relapsed MM 61 tubulin inhibitor 61 Darinaparsin 61 budesonide foam 61 antiangiogenic agent 61 novel peptides 61 antisense inhibitor 61 talabostat 61 cartilage regeneration 61 Serdolect ® 61 FLT3 61 isotypes 60 pomalidomide 60 BAY #-# 60 Nanobodies ® 60 cilengitide 60 potent anticancer 60 PEGylated interferon 60 tesmilifene 60 Trofex 60 vismodegib 60 anticoagulant reversing agent 60 AMD# [003] 60 TLE3 60 allogeneic HSCT 60 somatostatin analogue 60 JAK2 enzyme 60 CytoFabTM 60 OncoVEX GM CSF 60 zileuton 60 Aclidinium 60 lung metastasis 60 elvucitabine 60 Natalizumab 60 HER2 overexpression 60 Aurexis 60 demethylating agents 60 Litx 60 angiogenesis inhibitor 60 Fibrillex TM 60 somatostatin analog 60 ISTODAX 60 IAP inhibitors 60 topical gel containing 60 serotonin synthesis 60 Hsp# inhibitors 60 ASONEP 60 acadesine 60 Relivar 60 PKC# 60 TNFa 60 DOS# 60 myeloproliferative 60 echinocandin 60 DepoVax 60 phase IIa clinical 60 Zoraxel 60 BCR ABL inhibitors 60 Daclizumab 60 Radilex 60 potent inhibition 60 Kevetrin 60 Laquinimod 60 cidofovir 60 chemopreventive 60 Apoptone 60 CCR5 antagonist 60 HCV protease 60 Valproic acid 60 adalimumab Humira 60 Enzastaurin 60 mGlu2 3 60 Plicera 60 Psoraxine R 60 nucleotide analog 60 immune modulation 60 anti leukemic 60 FluCide 60 p# inhibitors 60 ATL# [002] 60 PTP 1B 60 VIPR2 60 CaPre TM 60 OMNARIS HFA 60 bactericidal activity 60 ACV1 60 pharmacodynamic properties 60 Cethromycin 60 TACI Ig 60 GSK3B 60 tranilast 60 midstage trials 60 PRTX 60 bioactive lipids 60 telomerase inhibition 60 erlotinib Tarceva ® 60 PSN# [001] 60 amifostine 60 IPL# 60 Bryostatin 60 Neovascular AMD 60 novel topoisomerase 60 CIMZIA TM 60 Lu AA# 60 Ocrelizumab 60 milatuzumab 60 Teriflunomide 60 EGS# 60 Seliciclib 60 abatacept Orencia 60 basal bolus regimen 60 FTIs 60 vorinostat 60 ZOLINZA 60 vemurafenib 60 Nanobody 60 drug GAP #B# 60 anti mitotic 60 prostanoid 60 leading oral taxane 60 thymidylate synthase 60 retaspimycin 60 PLX# 60 Telatinib 60 CB1 antagonists 60 posaconazole 60 androgen receptor AR 60 tanespimycin 60 silico prediction 60 MVA BN R 60 EndoTAGTM 1 60 Lisofylline LSF 60 orally bioavailable mimics 60 adrenergic regulation 60 Pertuzumab 60 nanoviricide 60 Ophena TM 60 Abiraterone acetate 60 viral kinetics 60 CYT# 60 KSP inhibitors 60 adenoviral 60 alpha interferon 60 potent inhibitor 60 Liprotamase 60 SPIRIVA HandiHaler 60 UPLYSO 60 muraglitazar 60 safinamide 60 orally dosed 60 Hepatotoxicity 60 ADAM# 60 neuroprotective effects 60 axitinib 60 GSK '# 60 Thiovir 60 MYDICAR ® 60 KB# [002] 60 biomarker identification 60 Beta catenin pathway 60 trastuzumab Herceptin 60 erlotinib Tarceva 60 Aflibercept 60 tigecycline 60 cardiac valvulopathy 60 Solulin 60 myelofibrosis polycythemia vera 60 epothilones 60 selective androgen receptor modulator 60 replicon 60 MTP inhibitors 60 sitaxsentan 60 RAPAFLO 60 antiangiogenic therapy 60 SinuNase ™ 60 histone deacetylase HDAC inhibitor 60 Crofelemer 60 pharmacological chaperone 60 NV1FGF 60 MAXY G# 60 ganaxolone 60 hyperprolactinemia 60 neuroprotectant 60 HER3 60 PRLX # 60 enzastaurin 60 LHRH agonists 60 roscovitine 60 Cariprazine 60 HMG CoA reductase inhibitors 60 EGFR tyrosine kinase inhibitors 60 renoprotective 60 trastuzumab Herceptin R 60 huN# DM1 60 cyclophilin inhibitors 60 sd rxRNA 60 Immunohistochemical analysis 60 herpetic keratitis 60 novel VDA molecule 60 lurasidone 60 OX1 60 anti EGFR antibody 60 rhIGFBP 3 60 MMP inhibitors 60 alvespimycin 60 BioVant 60 radiolabeled TM# 60 Eg5 60 humanized monoclonal 60 opioid antagonists 60 adenosine A2A 60 intranasal delivery 60 Viprovex TM 60 glucocorticoid receptor 60 GW# [003] 60 resolvins 60 antiproliferative effects 60 refractory gout 60 antidiabetic 60 liposomal formulation 60 nanoviricide drug 60 anti angiogenic 60 immune stimulatory 60 uPA 60 Opexa 60 FUS1 60 Valortim R 60 oncolytic virus 60 humanised monoclonal antibody 60 JAK2 inhibitors 59 vascular inflammation 59 angiogenesis inhibition 59 Hsp# inhibition 59 microtubule inhibitor 59 CDK inhibitor 59 recurrent glioblastoma multiforme 59 anti secretory 59 Milnacipran 59 tumor regressions 59 mecamylamine 59 Th# 59 PEDF 59 methylnaltrexone 59 goserelin 59 Tanespimycin 59 VDAs 59 effector function 59 isoform selective 59 Degarelix 59 mTOR inhibition 59 Vandetanib 59 Phase Ib study 59 Vernakalant 59 Viral Immunotherapy platform 59 mimetics 59 trastuzumab Herceptin ® 59 anti angiogenic drugs 59 Friedreich Ataxia FRDA 59 Anticalins ® 59 selectively inhibiting 59 induce apoptosis 59 chemokine receptor 59 IMiDs R 59 Dasatinib 59 Proxinium TM 59 inecalcitol 59 Perforomist ™ Inhalation Solution 59 entinostat 59 thiazolides 59 CD# antibody [001] 59 p# MAPK 59 adult mesenchymal stem 59 Cytolin R 59 experimentally induced 59 antitumor activity 59 RNAi therapeutic targeting 59 ibudilast 59 airway hyperresponsiveness 59 cynomolgus monkeys 59 E#F# 59 DexaSite 59 eprotirome 59 TMS Therapy 59 peptide fragments 59 PS# [001] 59 herpesviruses 59 CRD5 59 DMXAA 59 synthetic retinoid 59 Ampligen R 59 immatics 59 noninfectious uveitis 59 GMX# 59 eltrombopag 59 small molecule tyrosine 59 Interferon Beta 59 arterial thrombosis 59 camptothecin 59 Pimavanserin 59 5 HT2C receptor 59 lumiliximab 59 STAT3 signaling 59 TOLAMBA 59 malignant lymphomas 59 fluvastatin 59 therapeutic monoclonal antibodies 59 DNA hypermethylation 59 Maribavir 59 phase IIb study 59 JAK2 inhibitor 59 antiviral potency 59 Anticalins 59 enzyme inhibitor 59 laquinimod 59 Tß4 59 dexanabinol 59 COMT inhibitors 59 ATTR CM 59 EGFr 59 oral dihydropyrimidine dehydrogenase DPD 59 tumor xenograft models 59 phosphatidylserine PS targeting 59 Ceftaroline 59 MET amplification 59 Ceflatonin R 59 renin inhibitors 59 sulodexide 59 cytostatic 59 Talabostat 59 nalbuphine ER 59 antiarrhythmic 59 TRV# [001] 59 liver fibrosis 59 Valortim ® 59 ReN# 59 microRNA expression 59 Lisofylline 59 HuCAL antibodies 59 GLP toxicology studies 59 ARIKACE ™ 59 NPM1 59 hepatoma 59 biologic therapeutics 59 decitabine 59 GRNOPC1 contains 59 Bcr Abl mutations 59 Behcet uveitis 59 histone deacetylase HDAC 59 potent topoisomerase II 59 MabCampath 59 TTR gene 59 DiaKine 59 Anticalin R 59 TKM ApoB 59 BiTE antibody 59 Epothilones 59 antiapoptotic 59 Vidaza azacitidine 59 RGB # 59 sargramostim 59 investigational monoclonal antibody 59 Mitoxantrone 59 p# biomarker 59 sulindac 59 urocortin 2 59 Monoclonal antibody 59 upregulation 59 REG1 59 RECOTHROM R 59 Fabry Disease 59 imatinib Gleevec ® 59 Elafin 59 ProLindac TM 59 Neuropeptide Y 59 NNR Therapeutics 59 Oral NKTR 59 GAP #B# 59 TH# [003] 59 adipiplon 59 stable nucleic acid 59 calcitonin 59 Thalomid ® 59 DCVax R 59 NEUGENE R 59 XL# inhibits 59 TNFalpha 59 antithrombotic 59 tyrosine phosphorylation 59 BRAF inhibitors 59 NEUGENE antisense 59 Phase 2a trial 59 Campath ® 59 Exherin TM 59 transdifferentiation 59 mda 7 59 Gleevec imatinib mesylate 59 Phase IIB 59 systemic antifungal 59 endocrine therapies 59 MKC# MKC# PP 59 pharmacokinetic PK study 59 MGCD# [001] 59 pegylated liposomal doxorubicin 59 multicenter trials 59 Prestara 59 ANAVEX #-# [003] 59 SYN# 59 prucalopride 59 Onalta 59 TNF α 59 lipid lowering therapies 59 PI3K/Akt pathway inhibitor 59 CYP #A# 59 Vectibix monotherapy 59 INS# [001] 59 Velcade bortezomib 59 JVRS 59 baminercept 59 nucleoside analogues 59 anticancer therapy 59 Anidulafungin 59 siRNA delivery 59 Hedgehog pathway 59 PLK1 SNALP 59 evaluating tivozanib 59 alkylating agent 59 aripiprazole Abilify 59 GRNVAC1 59 GPR# [002] 59 DCCR 59 biomarker assay 59 vitro assay 59 itraconazole 59 alpha#beta# integrin 59 HTS assay 59 adipogenic 59 AKT1 59 potent antiproliferative 59 Hsp# inhibitor 59 Factor VEGF 59 TNF Tumor Necrosis Factor 59 cediranib 59 TLR9 agonists 59 Vidofludimus 59 Tavocept 59 Candesartan 59 signaling cascades 59 beta 1a 59 INCB# [002] 59 pDCs 59 busulfan 59 Calcitonin 59 anti VEGF 59 RAPTIVA 59 NMDA receptor antagonist 59 Janus kinase 59 ProMune 59 GAMMAGARD 59 GeoVax vaccine 59 Enkephalin 59 superficial bladder cancer 59 EKC Cide 59 AZILECT ® 59 visilizumab 59 Fludara ® 59 Homspera TM 59 intradermal injection 59 SGLT2 inhibitors 59 gastric adenocarcinoma 59 Tolvaptan 59 inhibitory effects 59 drug ISA# 59 GGF2 59 Kevetrin ™ 59 Solazed 59 tumor antigen 59 galanin 59 Octreolin 59 pradefovir 59 prostaglandin synthesis 59 NOX4 58 octreotide acetate 58 peptide antigens 58 immunological diseases 58 chemosensitivity 58 tumor vascular disrupting 58 NeuroVax TM 58 parkinsonian symptoms 58 p# inhibitor 58 Haptoglobin 58 CD# expression [001] 58 ALV# 58 kinase profiling 58 gemifloxacin 58 Debio 58 TREANDA 58 aclidinium 58 Antiangiogenic 58 oral JAK1 58 HDAC inhibitors 58 PDGFR 58 Imprime PGG 58 pharmacologic intervention 58 Angiocept 58 pterostilbene 58 Silodosin 58 bleomycin 58 transgene expression 58 P#X# 58 aurora kinase 58 Vascugel 58 REP# 58 Arsenic trioxide 58 Trabectedin 58 Eltrombopag 58 anti atherogenic 58 Lp PLA 2 58 vaso occlusive crisis 58 Erlotinib 58 ATHX 58 rxRNA 58 polymerase inhibitor 58 LNPs 58 HCV replication 58 Desmoteplase 58 FK# 58 imatinib therapy 58 humanized anti 58 Cloretazine 58 antisense oligonucleotide 58 TPI ASM8 58 prokinetic 58 Curaxin CBLC# 58 QTc prolongation 58 malignant transformation 58 Ribavirin causes 58 mitogen activated ERK kinase 58 EnzymeRx 58 EOquin TM 58 bicalutamide 58 Alemtuzumab 58 antiproliferative activity 58 CDK inhibitors 58 inhibiting mTOR